首页 | 本学科首页   官方微博 | 高级检索  
检索        

脂多糖结合蛋白在脓毒症患者诊断和预后预测中的作用
引用本文:焦京,蒋宇,高敏,王念,杨明施,肖献忠.脂多糖结合蛋白在脓毒症患者诊断和预后预测中的作用[J].中国病理生理杂志,2015,31(7):1294-1299.
作者姓名:焦京  蒋宇  高敏  王念  杨明施  肖献忠
作者单位:1. 湖南师范大学医学院生物化学与分子生物学教研室, 湖南 长沙 410006;
2. 中南大学 湘雅医学院病理生理学教研室, 湖南 长沙 410013;
3. 中南大学 湘雅三医院急危重症医学中心, 湖南 长沙 410013
摘    要:目的:探讨脂多糖结合蛋白(LBP)在脓毒症患者诊断和预后预测中的作用。方法:挑选ICU的患者共80名,患者分为全身炎症反应综合征(SIRS)组(阴性对照组)、脓毒症存活组和脓毒症死亡组;所有患者均于进入ICU后24 h内采集血清样本并进行APACHEⅡ评分分析;另挑选10名健康志愿者血清作为正常对照组;ELISA检测各组样本血清LBP、C反应蛋白(CRP)和降钙素原(PCT)浓度;并以APACHEⅡ评分、血清LBP、CRP和PCT浓度对脓毒症诊断和预后预测做ROC曲线,评价LBP在脓毒症患者诊断和预后预测中的作用。结果:与SIRS组相比,脓毒症组的APACHEⅡ评分、血清LBP、CRP、PCT浓度均升高(P0.05);与脓毒症存活组相比,死亡组的APACHEⅡ评分和血清LBP浓度升高(P0.05),而血清CRP和PCT浓度在脓毒症存活组与死亡组之间的差异无统计学意义;LBP血清浓度高于26.84 mg/L时诊断脓毒症的敏感性和特异性分别为97.1%和95.9%;LBP血清浓度高于54.16 mg/L时预测脓毒症预后的敏感性和特异性分别为85.2%和80.0%。结论:与传统的脓毒症生物标志物CRP、PCT相比,LBP在脓毒症的诊断和预测方面都具有更好的效果。

关 键 词:脓毒症  脂多糖结合蛋白  APACHEⅡ评分  C反应蛋白  降钙素原  
收稿时间:2015-01-28

Measurement of serum lipopolysaccharide binding protein for diagnosis and prognosis prediction in septic patients
JIAO Jing,JIANG Yu,GAO Min,WANG Nian,YANG Ming-shi,XIAO Xian-zhong.Measurement of serum lipopolysaccharide binding protein for diagnosis and prognosis prediction in septic patients[J].Chinese Journal of Pathophysiology,2015,31(7):1294-1299.
Authors:JIAO Jing  JIANG Yu  GAO Min  WANG Nian  YANG Ming-shi  XIAO Xian-zhong
Institution:1. Department of Biochemistry and Molecular Biology, Medical College, Hunan Normal University, Changsha 410006, China;
2. Department of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha 410013, China;
3. Department of Emergency and Critical Care Medicine, The Third Xiangya Hospital, Central South University, Changsha 410013, China
Abstract:AIM: To investigate the role of lipopolysaccharide binding protein (LBP) for diagnosis and prognosis prediction in the septic patients. METHODS: A total number of 80 ICU patients were enrolled. The patients were divided into systemic inflammatory response syndrome (SIRS) group and sepsis group, the patients in sepsis group were divided into non-survivor sub-group and survivor sub-group. We collected the serum samples and analyzed acute physiology and chronic health evaluation (APACHE) II score on the first day of the patients hospitalized in ICU. In addition, we also selected 10 healthy volunteers and collected their serum samples. The serum concentrations of LBP, C-reactive protein (CRP) and procalcitonin (PCT) were measured by ELISA. ROC analysis of LBP, CRP, PCT and APACHE II score was conducted to discriminate among critically ill patients with sepsis and predict the prognosis of the patients with sepsis. RESULTS: The levels of the 4 indicators in the septic patients were higher than those in the patients of SIRS (P<0.05). In addition, serum LBP and APACHE II score in the non-survivor sub-group were higher than those in the survivor sub-group (P<0.05), whereas no difference of the PCT and CRP levels between survivors and non-survivors with sepsis was observed. LBP levels greater than 26.84 mg/L had 97.1% sensitivity and 95.9% specificity to discriminate between SIRS and sepsis. LBP levels greater than 54.16 mg/L had 85.2% sensitivity and 80.0% specificity for prognosis of unfavorable outcome.CONCLUSION: LBP level was more accurately correlated with diagnosis or prognosis prediction than CRP or PCT in patients with sepsis.
Keywords:Sepsis  Lipopolysaccharide binding protein  APACHE II score  C-reactive protein  Procalcitonin
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号